

The new BHF Oxford Centre of Research Excellence (BHF Oxford CRE) has launched today at the University of Oxford. Building on three previous Centre awards since 2008, the BHF Oxford CRE unites the University’s cross-disciplinary cardiovascular research community. From discovery science through to clinical and population health research, the BHF Oxford CRE will continue to advance cardiovascular sciences and benefit for patients.
Professor Keith Channon, Director of the BHF Oxford CRE said “We are delighted to receive this renewed support from the BHF to continue the excellent research that is being done by our strong and diverse network of researchers in Oxford. With teams spanning across multiple disciplines we can address new targeted and critical areas of research for the cardiovascular sciences – with the overall goal of translating discoveries from the laboratory through to clinical practice. Through our early- to mid-career development and training opportunities we are continuing to promote a diverse and inclusive research culture allowing our researchers to compete at the highest level and nurture them to become future cardiovascular research leaders.”
With the new round of funding, the BHF Oxford CRE has three key research themes in areas where it sees clear potential to deliver world leading advances:
Led by Professor Cornelia van Duijn and co-led by Professor Blanca Rodriguez, the Big Data & Computational Science theme builds on the Centre’s capabilities in data analysis for population cardiovascular health, including a new focus on vascular dementia. We are working in collaboration between cardiologists, engineers and computer scientists to extend upon big data techniques, artificial intelligence, modelling and simulation which will provide new insights into treatments for cardiovascular disease.
Read the full story on the Radcliffe Department of Medicine website.
more recommended stories
Children’s Health in the United States is Declining!
Summary: A comprehensive analysis of U.S..
Autoimmune Disorders: ADA2 as a Therapeutic Target
Adenosine deaminase 2 (ADA2) has emerged.
Is Prediabetes Reversible through Exercise?
150 Minutes of Weekly Exercise May.
New Blood Cancer Model Unveils Drug Resistance
New Lab Model Reveals Gene Mutation.
Healthy Habits Slash Diverticulitis Risk in Half: Clinical Insights
Healthy Habits Slash Diverticulitis Risk in.
Caffeine and SIDS: A New Prevention Theory
For the first time in decades,.
Microbial Metabolites Reveal Health Insights
The human body is not just.
Reelin and Cocaine Addiction: A Breakthrough Study
A groundbreaking study from the University.
Preeclampsia and Stroke Risk: Long-Term Effects
Preeclampsia (PE) – a hypertensive disorder.
Statins and Depression: No Added Benefit
What Are Statins Used For? Statins.
Leave a Comment